Exploring Microsponge Technology: Applications Beyond Topical Drug Delivery

An ultra-innovative drug delivery method called Microsponge has been developed for oral or topical use. Entrapped medicinal compounds are shielded from physical and environmental deterioration by microsponges, which are porous microspheres composed of polymer and biologically inert. Microsponge sizes range from 5 to 300 μm in diameter. Microsponge delivery systems (MDS) have been the subject of several recent developments for the controlled release of medications onto the epidermis with the guarantee that the drug stays mostly localized and does not significantly enter the systemic circulation. MDS is a unique technology for the controlled release of topical medications. It is also utilized for the administration of oral medications and biopharmaceuticals, which include peptides, proteins, and DNA-based therapies. It is made up of microporous beads with diameters ranging from 10 to 25 microns, which are versatile enough to ensnaffle a variety of active substances. This review article includes information on patents and commercially available formulations along with techniques of preparation, release mechanism, characterisation, and uses of microsponge delivery systems.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-15
DOI
https://doi.org/10.5281/zenodo.14487858
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring Microsponge Technology: Applications Beyond Topical Drug Delivery

Zenodo (CERN European Organization for Nuclear Research)
Advanced Drug Delivery Systems
article

Exploring Microsponge Technology: Applications Beyond Topical Drug Delivery

article en

Abstract

An ultra-innovative drug delivery method called Microsponge has been developed for oral or topical use. Entrapped medicinal compounds are shielded from physical and environmental deterioration by microsponges, which are porous microspheres composed of polymer and biologically inert. Microsponge sizes range from 5 to 300 μm in diameter. Microsponge delivery systems (MDS) have been the subject of several recent developments for the controlled release of medications onto the epidermis with the guarantee that the drug stays mostly localized and does not significantly enter the systemic circulation. MDS is a unique technology for the controlled release of topical medications. It is also utilized for the administration of oral medications and biopharmaceuticals, which include peptides, proteins, and DNA-based therapies. It is made up of microporous beads with diameters ranging from 10 to 25 microns, which are versatile enough to ensnaffle a variety of active substances. This review article includes information on patents and commercially available formulations along with techniques of preparation, release mechanism, characterisation, and uses of microsponge delivery systems.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 65%
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.